Gene · 1075
NIH grants1,493
NIH grants whose papers are about the gene, through NIH's grant-paper links.
21 to 40 of 1,493
Download this page as JSON| Grant | Title | CTSC papers | Newest fiscal year |
|---|---|---|---|
| P30ES007033 | University of Washington Interdisciplinary Center for Exposures, Diseases, Genomics & Environment | 2 | 2025 |
| R01AT011729 | The VITamin D and OmegA-3 TriaL (VITAL): Post-Intervention Follow-Up | 2 | 2025 |
| R01CA097098 | Targeting the MUC1-C Oncoprotein in Triple-Negative Breast Cancer | 2 | 2025 |
| R01CA260249 | Dissecting new mechanisms of lysosome quality control in health and disease | 2 | 2025 |
| T32CA009302 | Leveraging innovative technologies in basic and clinical cancer research | 2 | 2025 |
| UL1TR002377 | Mayo Clinic Center for Clinical and Translational Science (CCaTS) | 2 | 2025 |
| ZIAAI000249 | The Pathogenesis, Diagnosis, and Treatment of Systemic Mast Cell Disorders | 2 | 2025 |
| ZIAAI000810 | Vector-Borne Diseases: Biology Of Vector Host Relationship | 2 | 2025 |
| ZIACL002119 | Develop novel assays for assessing cellular and gene therapies | 2 | 2025 |
| ZIAHL006004 | Olfactomedin 4- a key regulator of human neutrophil function, role in small intestinal adenocarcinoma. | 2 | 2025 |
| I01BX001991 | Molecular Mechanisms of Stellate Cell Activation in Liver Fibrosis | 1 | 2025 |
| I01CX002171 | "Dysregulated Polyamine Metabolism in H. pylori-associated Gastric Inflammation and Disease Progression" | 1 | 2025 |
| I01CX002473 | BCCMA: Targeting Gut-Microbiome in Veterans Deployment Related Gastrointestinal and Liver Diseases: Dysbiosis, PTSD, and Epithelial and Immune Biology in Inflammatory Bowel Disease in Veterans | 1 | 2025 |
| K01HL153792 | Identifying Genetic and Epigenetic Risk Factors Regulating Gene Expression for Childhood Asthma | 1 | 2025 |
| K08CA256045 | Enhancing the efficacy of Radiation Therapy for brainstem glioma by targeting ATM | 1 | 2025 |
| K08NS121519 | TDP43 Degradation by the Lysosomal Proteases in Amyotrophic Lateral Sclerosis | 1 | 2025 |
| K23DK125529 | Defining the molecular landscape of hyperfiltration-mediated glomerular injury using kidney allografts as a model system | 1 | 2025 |
| K24AA025704 | Clinical Neuroscience of Alcoholism: Integrating Neuroscience and Clinical Trials | 1 | 2025 |
| K24AG053435 | Neuropathological changes underlying clinical heterogeneity in Alzheimer disease | 1 | 2025 |
| K24DA048160 | Expanding Capacity for Addiction Regulatory Science Research and Mentoring | 1 | 2025 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1075/grants?page=2